XTalks

JUNE 30, 2023

Hemophilia A is a rare genetic bleeding disorder that is caused by a mutation in the gene that encodes the key blood clotting protein factor VIII (FVIII). Hemophilia A affects approximately one in 10,000 individuals and has a higher incidence than hemophilia B. The disorder primarily affects males.

Gene Therapy 98

Gene Therapy Gene FDA Approval Antibody 98

Drug Discovery World

JUNE 5, 2023

The panel was moderated by Alexander Nuyken, Head Life Sciences Markets Europe, Middle East & Africa, JLL. How can a biotech begin to shape and mould its culture, into something new and established?

Genome 52

Genome Genomics Life Science Genetics 52

XTalks

AUGUST 5, 2020

p-tau217 is a type of tau protein that forms the primary component of neurofibrillary tangles, which accumulate in the brain to give rise to the condition. The blood test can specifically detect the presence of this tau protein at significantly earlier stages, leading to the possibility of early diagnosis and treatment.

Protein 66

Protein Research Development Life Science 66

XTalks

FEBRUARY 16, 2023

Doctors often recommend focusing on improving sleep hygiene first by establishing a regular bedtime, reducing consumption of coffee and other stimulants and limiting screen time before bed. Outside of pharma marketing, Aniston can be seen in ads for skincare brand Aveeno and collagen supplement company Vital Proteins.

FDA Approval 105

FDA Approval Sales Branding Marketing 105

Drug Discovery World

APRIL 3, 2023

DS: What motivated you and Dr David Bunka, CTO, to create Aptamer and did you imagine you would one day be operating on such a global scale?    AT : We initially met at the University of Leeds, where David was a post-doctoral researcher studying aptamers, and I was completing my PhD. Optimer binders are engineered to overcome these problems.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

XTalks

JUNE 11, 2024

By using CAR-T cells targeted at CD19, a protein on the surface of these B cells, researchers hope to eliminate the cells responsible for the harmful antibodies. In lupus, B cells — part of the immune system — mistakenly attack the body’s own tissues, producing antibodies that lead to inflammation and damage.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52

Drug Discovery World

NOVEMBER 13, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Ali Madani, PhD, Founder and CEO, Profluent Bio, on: ‘Protein engineering with large language models’.

Protein 59

Protein Antibody Engineer Scientist 59

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Jonathan Fisher, PhD, Group Leader, University College London, on: ‘Local secretion of immune active proteins for direct and bystander tumour killing’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

Drug Discovery World

APRIL 21, 2023

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. Fröhlich, Post-Doctoral Researcher at CeMOS in Germany, and Steven Van Helden, Chief Technology Officer at Pivot Park Screening Centre in the Netherlands. It will be led by Björn C.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

XTalks

FEBRUARY 11, 2021

She was actually able to use the research for her doctoral thesis, graduating with a doctorate from Cambridge in 1945. The Hershey-Chase experiment is the historic study that solidified DNA as the carrier of genetic information over protein. Martha Chase: For the Books. Martha Chase.

Genetics 119

Genetics DNA Genome Genomics 119

pharmaphorum

SEPTEMBER 12, 2022

Across LabCorp , we innovate through science and technology, with access to approximately 2,500 [doctors] and PhDs and over 700 patients. Providers are creating individualised treatment plans for their patients based on their genes, proteins, or other bodily substances, resulting in better, faster, and more effective patient outcomes.

Genome 106

Genome Genomics Clinical Trials Clinical Trials 106

Drug Discovery World

OCTOBER 20, 2022

Dr Amber Miller, Flow Cytometry Scientist, Fortis Life Sciences, says flow cytometry techniques can help our understanding of cancer associated fibroblasts but there is still work to be done. She completed her PhD and post-doctoral training at Baylor College of Medicine. Imaging mass cytometry. 2016;165(4):780-791. 2016.04.019.

Antibody 52

Antibody In-Vivo Life Science Development 52

Drug Discovery World

NOVEMBER 10, 2023

I went on from studying transgenic mice expressing Latent Membrane Protein 1 of Epstein Barr Virus using proteomics, molecular biology and biochemistry techniques to delineating the contribution of LMP1 to viral induced carcinogenesis.

Antibody 59

Antibody Clinical Trials Clinical Trials Life Science 59

XTalks

AUGUST 26, 2021

Portfolio diet foods include nuts; beans; tofu; soy-based plant protein; viscous soluble fiber from oats, barley, okra, eggplant, oranges, apples and berries; plant sterols from enriched foods and monounsaturated fats found in avocadoes as well as olive and canola oil; as well as limited consumption of saturated fats and dietary cholesterol.

Research 52

Research Development Production Life Science 52

XTalks

NOVEMBER 11, 2021

The COVID-19 vaccine patent is for the specific genetic sequence of the spike protein used in the Spikevax vaccine. However, the US continues to be accused of vaccine hoarding by groups like Doctors Without Borders. Moderna had promised that it would not impose patents on its vaccine during the pandemic.

Vaccination 98

Vaccination Vaccine Scientist Contract Manufacturing 98

XTalks

NOVEMBER 11, 2020

It was then modified in the lab to effectively recognize and bind to the spike (S) protein that covers the outer surface of the virus, blocking the antigen from attaching to host cells to prevent infection.

Antibody 59

Antibody Drugs Trials FDA Approval 59

XTalks

SEPTEMBER 14, 2020

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. The University of Oxford/AstraZeneca partnership, in turn, is testing a viral-vectored coronavirus vaccine that again expresses the spike protein of SARS-CoV-2 virus. The mask costs all of about $40 to make.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92